Publications by authors named "Amy M Lin"

Claim this Profile
F
Factors Associated With Participation in the Chronic Disease Self-Management Program: Findings From the SUCCEED Trial.
Amy M Lin, Barbara G Vickrey, Frances Barry, Martin L Lee, Monica Ayala-Rivera

Stroke· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study.
Mina Lee, Haemin Hong, Won Kim, Li Zhang, Terence W Friedlander, Amy M Lin

Clin Genitourin Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less Than Ideal: Trends in Cardiovascular Health Among US Stroke Survivors.
Amy M Lin, Michelle P Lin, Daniela Markovic, Bruce Ovbiagele, Nerses Sanossian

Stroke· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone- and/or Enzalutamide-Refractory Metastatic Castration-Resistant Prostate Cancer.
Xiao X Wei, Adam P Siegel, Rahul Aggarwal, Amy M Lin, Terence W Friedlander

Oncologist· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer.
Terence W Friedlander, Julie N Graff, Kreshnik Zejnullahu, Archana Anantharaman, Li Zhang, Amy M Lin

Clin Genitourin Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer.
Xiao X Wei, Andrew C Hsieh, Won Kim, Terence Friedlander, Amy M Lin

Oncologist· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study.
Rahul Aggarwal, Alan Bryce, Charles J Ryan, Andrea Harzstark, Christina Derleth, Amy M Lin

Urol Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer.
Xiao X Wei, Stephen Chan, Serena Kwek, Jera Lewis, Vinh Dao, Amy M Lin

Cancer Immunol Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab.
Serena S Kwek, Jera Lewis, Li Zhang, Vivian Weinberg, Samantha K Greaney, Amy M Lin

Cancer Immunol Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF.
Rahul R Aggarwal, Tomasz M Beer, Vivian K Weinberg, Celestia Higano, Mary-Ellen Taplin, Amy M Lin

Clin Genitourin Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens.
Won Kim, Li Zhang, John H Wilton, Gerald Fetterly, James L Mohler, Amy M Lin, Arturo Molina

Clin Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR.
Brigette L Tippin, Alan M Kwong, Michael J Inadomi, Oliver J Lee, Jae Man Park, Amy M Lin, Henry J Lin

Cancer Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study.
Terence W Friedlander, Vivian K Weinberg, Eric J Small, Jeremy Sharib, Andrea L Harzstark, Amy M Lin

Urol Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.
Brigette L Tippin, A Joan Levine, Alicia M Materi, Wen-Liang Song, Temitope O Keku, Amy M Lin, John M Lin, Henry J Lin

Prostaglandins Other Lipid Mediat· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.
Terence W Friedlander, Vivian K Weinberg, Yong Huang, Joanna T Mi, Carl G Formaker, Amy M Lin

Oncol Rep· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma.
Andrea L Harzstark, Eric J Small, Vivian K Weinberg, Janine Sun, Charles J Ryan, Amy M Lin

Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor fistulization associated with targeted therapy: computed tomographic findings and clinical consequences.
Henry Chow, Adam Jung, Jason Talbott, Amy M Lin, Adil I Daud

J Comput Assist Tomogr· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (cblC) detected through low carnitine levels on newborn screening.
Henry J Lin, Julie A Neidich, Denise Salazar, Evangela Thomas-Johnson, Barbara F Ferreira, Amy M Lin

J Pediatr· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.
Lawrence Fong, Serena S Kwek, Shaun O'Brien, Brian Kavanagh, Douglas G McNeel, Amy M Lin

Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer update: 2007.
Amy M Lin, Eric J Small

Curr Opin Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of hormone refractory prostate cancer.
Amy M Lin, Eric J Small

Curr Opin Support Palliat Care· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer.
Amy M Lin, Brian I Rini, Mika K Derynck, Vivian Weinberg, Margaret Park

Clin Genitourin Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer update: 2006.
Amy M Lin, Eric J Small

Curr Opin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent chemotherapy for metastatic hormone refractory prostate cancer.
Amy M Lin, Charles J Ryan, Eric J Small

Crit Rev Oncol Hematol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells.
Amy M Lin, Robert M Hershberg, Eric J Small

Urol Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis